Form 4 for ESLA Estrella Immunopharma, Inc.

Accepted 2026-04-29 21:36:42 ET · period of report 2025-09-11 · accession 0001213900-26-049602 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
M	2026-04-29 21:36	2025-09-11+	ESLA	Xu Jiandong	CFO	P - Purchase	$1.30	+1,100	265.5K	+0.4%	+$1,434
I	2026-04-29 21:36	2025-09-22	ESLA	Xu Jiandong	CFO	P - Purchase	$1.16	+1,000	16.7K	+6%	+$1,160

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock, par value $0.0001 per share	2025-09-11	P	A	100	$1.04	264,588	D	—	—
2	Common	Common Stock, par value $0.0001 per share	2025-09-22	P	A	1,000	$1.16	16,700	I By Spouse	—	—	(F1) Held by the Reporting Person's spouse. The Reporting Person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose. (F1) Held by the Reporting Person's spouse. The Reporting Person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.
3	Common	Common Stock, par value $0.0001 per share	2025-10-07	P	A	1,000	$1.33	265,488	D	—	—